Outside of OS, there have been several translational and clinical studies demonstrating mixed prognostic outcomes related to increased ALDH expression. Chang et al. studied 442 patients with ovarian cancer and found high ALDH1A1 expression correlated with favorable survival and improved response to chemotherapy [29]. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.